lysine has been researched along with Diabetic Retinopathy in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.89) | 18.7374 |
1990's | 12 (22.64) | 18.2507 |
2000's | 20 (37.74) | 29.6817 |
2010's | 18 (33.96) | 24.3611 |
2020's | 2 (3.77) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Li, C; Li, L; Liu, L; Yang, K; Yang, X; Yu, H; Zhang, H | 1 |
Guo, F; Li, Z; Liu, J; Liu, Y; Ma, X; Meng, D; Qin, G; Wang, J; Wu, L; Xu, L; Zhang, H; Zhang, L; Zhao, D; Zhao, S; Zhao, Y | 1 |
Ando, R; Dong, Y; Dong, Z; Ishida, S; Kanda, A; Kawasaki, A; Mori, S; Murata, M; Noda, K; Saito, M; Saito, W; Yoshida, S | 1 |
Bharathidevi, SR; Coral, K; Ramya, R; Sulochana, KN; Vidhya, S | 1 |
Augustine, J; Barabas, P; Chen, M; Chevallier, O; Curtis, TM; McCarron, P; McDowell, RE; McGeown, JG | 1 |
Chua, KH; Iqbal, T; Kuppusamy, UR; Ng, ZX | 2 |
Borsos, AM; M'bemba, J; Peyroux, J; Selam, JL; Slama, G; Sternberg, M; Urios, P | 1 |
Khanna, VK; Kruzliak, P; Meyer, CH; Mishra, N; Saxena, S; Shukla, RK; Singh, V | 1 |
Gaspar, L; Khanna, V; Kruzliak, P; Mishra, N; Prasad, S; Ruia, S; Saxena, S; Singh, V; Staffa, R | 1 |
Dong, Y; Ishida, S; Kanda, A; Murata, M; Noda, K; Saito, W; Yoshida, S | 1 |
Fokkens, BT; Los, LI; Mulder, DJ; Schalkwijk, CG; Scheijen, JL; Smit, AJ | 1 |
Curtis, TM; Gardiner, TA; Lai, Y; McCance, DR; McDonald, DM; Stitt, AW; Uchida, K; Zhang, X | 1 |
Grossin, N; Guillausseau, PJ; Massin, P; Meas, T; Wautier, JL; Wautier, MP | 1 |
Baum, L; Chan, JC; Chan, WM; Chan, YM; Choy, KW; Fan, BJ; Fung, NS; Lam, DS; Li, H; Liu, DT; Louey, JW; Pang, CP | 1 |
Osredkar, J; Petrovic, D; Petrovic, MG; Saraga-Babić, M | 1 |
Al-Zawahary, WM; Mansour, DE; Radwan, AA; Salman, AG; Swelem, AH | 1 |
Hara, H; Ikeda, T; Izuta, H; Matsunaga, N; Shimazawa, M; Sugiyama, T | 1 |
Curtis, TM; Limb, GA; Medina, RJ; Stitt, AW; Uchida, K; Yong, PH; Zong, H | 1 |
Kim, CS; Kim, J; Kim, JS; Sohn, E | 1 |
Aiello, LP; Asztalos, BF; Cavallerano, JD; Doria, A; Keenan, HA; King, GL; Monnier, VM; Schaefer, EJ; Sell, DR; Strauch, CM; Sun, JK | 1 |
Nagaoka, T; Sato, E; Takahashi, A; Yokota, H; Yoshida, A | 1 |
Ben Yahya, S; Bouzidi, H; Hammami, M; Kerkeni, M; Saïdi, A | 1 |
Ben Yahia, S; Bouzidi, H; Hammami, M; Kerkeni, M; Letaief, A; Saïdi, A | 1 |
Bhadhuri, G; Bhattacharya, B; Choudhuri, S; Chowdhury, IH; Dutta, D; Mitra, B; Mondal, LK; Saha, A; Sen, A | 1 |
Alderson, NL; Anderson, NL; Baynes, JW; Boyle, C; Canning, P; Chachich, M; Duffy, N; Frizzell, N; Gardiner, TA; Januszewski, AS; Stitt, A; Thorpe, SR | 1 |
Biswas, J; Kumar, SK; Miriam, KC; Nagaraj, RH; Ramakrishnan, S; Sulochana, KN; Swamy-Mruthinti, S | 1 |
Fujinami, A; Hasegawa, G; Ikeda, T; Imamura, Y; Kinoshita, S; Nakamura, N; Nakano, K; Obayashi, H; Ogata, M; Ohta, M; Watanabe, A; Yamazaki, M; Yoshikawa, T | 1 |
Chiavaroli, C; Garay, RP; Hannaert, P; Rota, R | 1 |
Boehm, BO; Kientsch-Engel, R; Lang, GE; Lang, GK; Rosinger, S; Schilling, S; Stahl, P | 1 |
Hirata, K; Kubo, K | 1 |
De Rojas Silva, MV; Rodríguez-García, J; Rodríguez-Segade, S; Sánchez-Salorio, M; Tomé, CC | 1 |
Berkowitz, BA; Connor, JR; Hohman, TC; Knoerzer, DL; Luan, H; Peysakhov, J; Roberts, R | 1 |
Cleary, P; Dahms, W; Genuth, S; Malone, J; Monnier, VM; Sell, DR; Sivitz, W; Sun, W | 1 |
Fukuhara, M; Fukui, M; Hasegawa, G; Ikeda, T; Nakamura, N; Obayashi, H; Ohta, M; Oku, H; Okuno, T; Sugiyama, T | 1 |
Khosrof, S; Nagaraj, R; Sady, C | 1 |
Bailie, KE; Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ; McCance, DR; Thorpe, SR | 1 |
Brandt, R; Hanschke, R; Hartmann, K; Hehmke, B; Jäger, B; Kasbohm, J; Krantz, S; Landmesser, C; Michaelis, D; Vogt, L | 1 |
Blanco, MC; Camejo, M; Contreras, I; Giansante, E; Gonzalez, F; Lopez, T; Martinez, N; Molina, M; Postalian, S; Reiser, KM; Sanchez, MR; Suarez, N | 1 |
Horiuchi, S; Ikeda, K; Inomuta, H; Ishibashi, T; Murata, T; Nagai, R | 1 |
Arai, K; Chikuda, M; Hashimoto, H; Obara, Y | 1 |
Kawashima, S; Kurokawa, K; Maeda, K; Miyata, T; Sugiyama, S; Tanaka, H; Ueda, Y; Van Ypersele de Strihou, C | 1 |
Aotaki-Keen, A; Handa, JT; Hjelmeland, LM; Lutty, GA; Matsunaga, H; Miyata, T; te Koppele, JM; Verzijl, N | 1 |
Bretzel, RG; Brownlee, M; Hammes, HP; Lin, J; Schleicher, E | 1 |
Hamada, Y; Horiuchi, S; Hotta, N; Kasuya, Y; Kato, K; Komori, T; Nagai, R; Nakamura, J; Naruse, K | 1 |
Fedele, D; Lapolla, A; Traldi, P | 1 |
Engerman, RL; Kern, TS | 1 |
Endo, M; Higuchi, M; Koike, T; Makita, Z; Matsuda, A; Matsushita, T; Okamoto, T; Takeuchi, M; Tsuchida, K; Yanagisawa, K | 1 |
Matsumoto, Y; Ogata, M; Takahashi, M | 1 |
Fogarty, J; Lapolla, A; Monnier, VM; Odetti, P; Sell, DR | 1 |
Buckingham, B; Charles, MA; Reiser, K; Sebag, J | 1 |
Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ; Silvestri, G | 1 |
Baba, S; Hata, F; Hatanaka, H; Kitamura, Y; Maeda, Y; Matsumoto, S; Nishimoto, S; Oimomi, M | 1 |
1 review(s) available for lysine and Diabetic Retinopathy
Article | Year |
---|---|
AGE in micro- and macroangiopathy.
Topics: Aging; Animals; Arginine; Arteriosclerosis; Cell Adhesion; Collagen; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Interferon-gamma; Lysine; Membrane Proteins; Microcirculation; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; T-Lymphocytes; Vascular Diseases | 2001 |
3 trial(s) available for lysine and Diabetic Retinopathy
Article | Year |
---|---|
Soluble receptor for advanced glycation end-product (sRAGE)/pentosidine ratio: a potential risk factor determinant for type 2 diabetic retinopathy.
Topics: Adult; Advanced Oxidation Protein Products; Aged; Arginine; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glutathione Peroxidase; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Risk Factors; Superoxide Dismutase | 2013 |
Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM.
Topics: Analysis of Variance; Arginine; Aspirin; Biopsy; Blood Glucose; Collagen; Cross-Linking Reagents; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Double-Blind Method; Glycated Hemoglobin; Lysine; Placebos; Skin | 1997 |
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Analysis of Variance; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Myocardial Ischemia; Regression Analysis; Sensitivity and Specificity; Severity of Illness Index | 1998 |
49 other study(ies) available for lysine and Diabetic Retinopathy
Article | Year |
---|---|
Metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in patients with type 2 diabetes.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Gastrointestinal Microbiome; Humans; Lysine | 2022 |
Long noncoding RNA Hotair facilitates retinal endothelial cell dysfunction in diabetic retinopathy.
Topics: Animals; Antigens, CD; Cadherins; Diabetic Retinopathy; Endothelial Cells; Gene Expression Regulation; Gene Knockdown Techniques; Glucose; Histone Demethylases; Histones; Hypoxia-Inducible Factor 1, alpha Subunit; Lysine; Male; Methylation; Mice, Inbred C57BL; Promoter Regions, Genetic; Retina; Retinal Vessels; RNA, Long Noncoding; Vascular Endothelial Growth Factor A | 2020 |
Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
Topics: Acrolein; Aged; Amine Oxidase (Copper-Containing); Blotting, Western; Cell Adhesion Molecules; Cell Survival; Cells, Cultured; Diabetic Retinopathy; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Glutathione; Humans; Hydrogen Peroxide; Lysine; Male; Middle Aged; Oxidation-Reduction; Retinal Vessels; Spermine; Vitreous Body | 2017 |
Free amino acids hydroxyproline, lysine, and glycine promote differentiation of retinal pericytes to adipocytes: A protective role against proliferative diabetic retinopathy.
Topics: Adipocytes; Adiponectin; Animals; Cattle; Cell Differentiation; Cells, Cultured; Chromatography, High Pressure Liquid; Diabetic Retinopathy; Glycine; Glycoproteins; Humans; Hydroxyproline; Intercellular Signaling Peptides and Proteins; Lysine; Pericytes; PPAR gamma; Real-Time Polymerase Chain Reaction; Retinal Perforations; Retinal Vessels; Vitreous Body | 2018 |
Müller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4,6-dimethylpyrimidine.
Topics: Acrolein; Animals; Cell Survival; Chromatography, Liquid; Diabetic Retinopathy; Electroretinography; Enzyme-Linked Immunosorbent Assay; Ependymoglial Cells; Free Radical Scavengers; Immunohistochemistry; Lysine; Male; Mass Spectrometry; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2018 |
Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy.
Topics: Adult; Advanced Oxidation Protein Products; Aged; Arginine; Biomarkers; Chemokine CCL2; Diabetic Retinopathy; Female; Genotype; Glutathione Peroxidase; Glycation End Products, Advanced; Humans; Inflammation; Lysine; Male; Middle Aged; NF-kappa B; Polymorphism, Genetic; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Superoxide Dismutase | 2013 |
Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Biopsy; Case-Control Studies; Collagen; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Female; Fluorescence; Humans; Longitudinal Studies; Lysine; Male; Middle Aged; Skin; Spectrometry, Fluorescence | 2016 |
Association of serum N(ε)-Carboxy methyl lysine with severity of diabetic retinopathy.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Severity of Illness Index | 2016 |
Increased levels of N(ε)- Carboxy methyl lysine (N(ε)-CML) are associated with topographic alterations in retinal pigment epithelium: A preliminary study.
Topics: Adult; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Glycated Hemoglobin; Humans; Lysine; Male; Middle Aged; Prospective Studies; Regression Analysis; Retinal Pigment Epithelium; Severity of Illness Index; Tertiary Care Centers; Up-Regulation; Vitreoretinopathy, Proliferative | 2016 |
Localization of Acrolein-Lysine Adduct in Fibrovascular Tissues of Proliferative Diabetic Retinopathy.
Topics: Acrolein; Actins; Adult; Aged; Antigens, CD34; Cell Proliferation; Cell Survival; Cells, Cultured; Diabetic Retinopathy; Endothelium, Vascular; Female; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Heme Oxygenase-1; Humans; Lysine; Male; Middle Aged; Paraffin Embedding; Real-Time Polymerase Chain Reaction; Retinal Neovascularization; Retinal Vessels; RNA, Messenger; Young Adult | 2017 |
Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Retinal Detachment | 2017 |
Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy.
Topics: Antibodies, Monoclonal; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Humans; Hyperglycemia; Lysine; Reference Values; Severity of Illness Index; White People | 2008 |
Severity of diabetic microvascular complications is associated with a low soluble RAGE level.
Topics: Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2008 |
EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes.
Topics: Age of Onset; Aged; Asparagine; Case-Control Studies; China; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelin-1; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Hypertension; Lysine; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Regression Analysis | 2008 |
K469E polymorphism of the intracellular adhesion molecule 1 gene is associated with proliferative diabetic retinopathy in Caucasians with type 2 diabetes.
Topics: Aged; Alanine; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Genetic Predisposition to Disease; Genotype; Glutamic Acid; Glycine; Humans; Intercellular Adhesion Molecule-1; Lysine; Male; Middle Aged; Polymorphism, Genetic; Slovenia; White People | 2008 |
Pentosidine - a new biochemical marker in diabetic retinopathy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; Blood Proteins; Case-Control Studies; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Disease Progression; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged | 2009 |
Proliferative diabetic retinopathy and relations among antioxidant activity, oxidative stress, and VEGF in the vitreous body.
Topics: Antioxidants; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Oxidative Stress; Retinal Perforations; Vascular Endothelial Growth Factor A; Vitreous Body | 2010 |
Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy.
Topics: Animals; Antibody Specificity; Cell Death; Diabetic Retinopathy; Epitopes; Flow Cytometry; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glycated Hemoglobin; Immunohistochemistry; Inflammation; Lipids; Lysine; Male; Models, Biological; Neuroglia; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Retina; Time Factors | 2010 |
Elevated Nε-(carboxymethyl)lysine is associated with apoptosis of retinal pericytes in streptozotocin-induced diabetic rats.
Topics: Animals; Apoptosis; Caspase 3; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Fluorescent Antibody Technique, Indirect; Glycation End Products, Advanced; In Situ Nick-End Labeling; Lysine; NF-kappa B; Pericytes; Rats; Rats, Sprague-Dawley; Retinal Vessels | 2011 |
Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.
Topics: Aged; Arginine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged | 2011 |
Correlation between plasma pentosidine concentrations and retinal hemodynamics in patients with type 2 diabetes.
Topics: Arginine; Blood Flow Velocity; Blood Glucose; Body Constitution; Cholesterol; Cross-Linking Reagents; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Hemodynamics; Humans; Laser-Doppler Flowmetry; Lysine; Male; Middle Aged; Prospective Studies; Retinal Artery | 2012 |
Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
Topics: Aged; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis; Tunisia | 2012 |
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Topics: Aged; Arginine; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Hyperlipidemias; Hypertension; Lysine; Male; Microvessels; Middle Aged; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Up-Regulation | 2013 |
Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Topics: Adult; Aged; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycation End Products, Advanced; Humans; Leukocytes, Mononuclear; Lysine; Male; Middle Aged; Reactive Oxygen Species; Sulfhydryl Compounds; Vitreous Body | 2013 |
The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.
Topics: Animals; Capillaries; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Extracellular Matrix; Female; Glycation End Products, Advanced; Laminin; Lysine; Pyridoxamine; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; RNA, Messenger | 2002 |
Immunolocalization and quantification of advanced glycation end products in retinal neovascular membranes and serum: a possible role in ocular neovascularization.
Topics: Adolescent; Adult; Blood Glucose; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Epiretinal Membrane; Female; Glycation End Products, Advanced; Humans; Immunoenzyme Techniques; Lysine; Male; Middle Aged; Pyruvaldehyde; Retinal Neovascularization; Retinal Vasculitis | 2002 |
Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy.
Topics: Adult; Aged; Arginine; Cohort Studies; Cross-Linking Reagents; Diabetic Retinopathy; Female; Glycation End Products, Advanced; Humans; Interleukin-6; Lysine; Male; Middle Aged; Retina; Vitreous Body | 2003 |
Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Topics: Albumins; Animals; Antioxidants; Blood-Retinal Barrier; Calcium Dobesilate; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glycation End Products, Advanced; Hemostatics; Immunohistochemistry; Lysine; Male; Rats; Rats, Wistar; Retina; Vascular Endothelial Growth Factor A | 2004 |
Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Lysine; Macular Degeneration; Male; Middle Aged | 2004 |
Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged | 2004 |
Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
Topics: Arginine; Biomarkers; Chromatography, High Pressure Liquid; Diabetic Retinopathy; Glycation End Products, Advanced; Glycosylation; Humans; In Vitro Techniques; Lysine; Middle Aged; Retinal Detachment; Severity of Illness Index; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2005 |
Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy.
Topics: Animals; Blood Glucose; Carbon Dioxide; Celecoxib; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme Inhibitors; Lysine; Magnetic Resonance Imaging; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxygen; Oxygen Consumption; Partial Pressure; Pyrazoles; Rats; Retina; Sulfonamides | 2005 |
Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications p
Topics: Adult; Biopsy; Collagen; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Disease Susceptibility; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Prognosis; Skin; Time Factors | 2005 |
Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Drug Evaluation, Preclinical; Electroretinography; Gene Expression Regulation; Glycation End Products, Advanced; Lysine; Male; Rats; Rats, Sprague-Dawley; Retina; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Vascular Endothelial Growth Factor A | 2007 |
Advanced Maillard reaction and crosslinking of corneal collagen in diabetes.
Topics: Antioxidants; Arginine; Collagen; Cornea; Cross-Linking Reagents; Diabetes Mellitus; Diabetic Retinopathy; Glycation End Products, Advanced; Humans; Hydroxyproline; Lysine; Maillard Reaction; Pepsin A; Pyridines | 1995 |
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Maillard Reaction; Male; Microcirculation; Middle Aged; Skin | 1993 |
Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significance.
Topics: Adult; Age of Onset; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Female; Fructosamine; Glycated Hemoglobin; Humans; Lysine; Macrophages; Male; Membrane Proteins; Middle Aged; Monocytes; Nuclear Proteins; Probability; Rats; Rats, Inbred BB; Reference Values; RNA-Binding Proteins | 1996 |
The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas.
Topics: Aged; Aged, 80 and over; Antibodies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelial Growth Factors; Epitopes; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lymphokines; Lysine; Male; Middle Aged; Retina; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1997 |
[Relationship between vascular endothelial growth factors and advanced glycation end products in the human vitreous].
Topics: Adult; Arginine; Cytokines; Diabetic Retinopathy; Disease Progression; Endothelial Growth Factors; Glycation End Products, Advanced; Humans; Lymphokines; Lysine; Middle Aged; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitreous Body | 1998 |
Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Bruch Membrane; Choroid; Chromatography, High Pressure Liquid; Diabetic Retinopathy; Glycation End Products, Advanced; Humans; Immunoenzyme Techniques; Infant; Lysine; Middle Aged; Pigment Epithelium of Eye; Retinal Drusen | 1999 |
Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.
Topics: Adult; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Leukocyte Common Antigens; Lysine; Male; Middle Aged; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyruvaldehyde; Risk Factors; T-Lymphocytes | 1999 |
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Topics: Aldehyde Reductase; Blood Glucose; Blood Proteins; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Reference Values; Rhodanine; Thiazolidines | 2000 |
Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.
Topics: Albumins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Aspirin; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dogs; Glycated Hemoglobin; Glycation End Products, Advanced; Glycosuria; Guanidines; Kidney; Lysine; Neural Conduction; Platelet Aggregation; Random Allocation; Retinal Vessels; Ulnar Nerve | 2001 |
Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
Topics: Aged; Aqueous Humor; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Endothelial Growth Factors; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lymphokines; Lysine; Male; Middle Aged; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
[Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy].
Topics: Arginine; Cytokines; Diabetic Retinopathy; Glycation End Products, Advanced; Humans; Hydrogen Peroxide; Lysine; Vitreous Body | 2001 |
Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.
Topics: Adult; Arginine; Collagen; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Models, Biological; Reference Values; Skin; Skin Aging | 1992 |
Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Collagen; Diabetic Retinopathy; Dipeptides; Female; Fluorometry; Humans; Lysine; Male; Middle Aged; Vitreous Body | 1992 |
Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts.
Topics: Aged; Arginine; Cataract; Cataract Extraction; Crystallins; Diabetic Retinopathy; Female; Glycosylation; Humans; Lysine; Male | 1991 |
Glycosylation levels of nail proteins in diabetic patients with retinopathy and neuropathy.
Topics: Adult; Aged; Diabetes Mellitus; Diabetic Neuropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Nails | 1985 |